Efficacy and safety of recombinant human tumor necrosis factor application for the treatment of malignant pleural effusion caused by lung cancer

Malignant pleural effusion (MPE) signifies a poor prognosis for patients with lung cancer. For treating physicians, the primary goals are to achieve sufficient control of MPE and minimize invasive intervention. Recombinant human mutant tumor necrosis factor‐alpha (rhu‐TNF) has been used in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Sun, Wenkui, Yuan, Dongmei, Lv, Tangfeng, Yin, Jie, Cao, Ehong, Xiao, Xinwu, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718129/
https://www.ncbi.nlm.nih.gov/pubmed/26816548
http://dx.doi.org/10.1111/1759-7714.12296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718129/
https://www.ncbi.nlm.nih.gov/pubmed/26816548
http://dx.doi.org/10.1111/1759-7714.12296

Ejemplares similares